Dec 18 (Reuters) - Moderna Inc MRNA.O :
* STATEMENT ON THE U.S. AUTHORIZATION OF THE MODERNA COVID-19 VACCINE
* HEALTH CANADA SAYS IS AWARE U.S. FOOD AND DRUG ADMINISTRATION HAS ISSUED EMERGENCY USE AUTHORIZATION FOR A COVID-19 VACCINE MANUFACTURED BY MODERNA
* HEALTH CANADA SAYS HAS BEEN REVIEWING MODERNA'S VACCINE SINCE IT WAS SUBMITTED ON OCTOBER 12, 2020, AND IS EXPEDITING REVIEW OF COVID-19 VACCINES
* HEALTH CANADA SAYS THERE IS STILL INFORMATION, DATA TO BE PROVIDED BY MODERNA FOR REVIEW
* HEALTH CANADA SAYS CANNOT PROVIDE A DEFINITE TIMELINE FOR COMPLETION OF VACCINE REVIEW AT THIS TIME
* HEALTH CANADA SAYS REVIEW IS EXPECTED TO BE COMPLETED IN COMING WEEKS
* HEALTH CANADA SAYS IS WORKING CLOSELY WITH INTERNATIONAL REGULATORS, INCLUDING U.S. FDA, TO SHARE INFORMATION, DATA ON VACCINES UNDER REVIEW
* HEALTH CANADA SAYS REVIEW IS BEING DONE THROUGH ROLLING SUBMISSIONS, WHERE DATA IS BEING REVIEWED AS IT BECOMES AVAILABLE FROM MANUFACTURER